HSV-7

HSV-7
Name	HSV-7
Virus group	DNA virus
Family	Herpesviridae
Subfamily	Betaherpesvirinae
Genus	Roseolovirus
Species	Human herpesvirus 7
Genome	Linear double-stranded DNA
Capsid	Icosahedral
Hosts	Humans

HSV-7

HSV-7 is a human betaherpesvirus historically classified within the roseolovirus group. First associated with febrile illnesses in infants during the mid-20th century, HSV-7 has been investigated in contexts that include pediatric infectious disease, immunology, virology, and epidemiology. Research into HSV-7 intersects with work from laboratories, hospitals, and public health agencies worldwide.

Taxonomy and Virology

HSV-7 is placed in the family Herpesviridae, subfamily Betaherpesvirinae, genus Roseolovirus, alongside relatives characterized by nuclear replication and lifelong latency. Taxonomic discussions have involved institutions such as the International Committee on Taxonomy of Viruses, and comparative genomic analyses reference sequences used by laboratories at institutions including the Pasteur Institute, Centers for Disease Control and Prevention, and Max Planck Institute. The viral particle shows an icosahedral capsid enclosed by a tegument and envelope with glycoproteins homologous to those studied in HHV-6 investigations at universities like Harvard University and University of Cambridge. Genomic organization comparisons cite conserved open reading frames noted in analyses from National Institutes of Health groups and collaborators at University of Oxford and Johns Hopkins University.

HSV-7 replication includes immediate-early, early, and late gene expression patterns resembling those documented for other betaherpesviruses in publications from Cold Spring Harbor Laboratory and sequencing efforts at Sanger Institute. Studies of virion assembly reference electron microscopy techniques pioneered at Max Planck Institute for Biophysical Chemistry and biochemical work from Karolinska Institutet.

Epidemiology and Transmission

Epidemiological work on HSV-7 has drawn on cohort studies conducted in settings such as pediatric clinics affiliated with Great Ormond Street Hospital, community surveys by World Health Organization, and seroprevalence panels used by national agencies like Public Health England and the Centers for Disease Control and Prevention. Transmission pathways postulated in outbreak reports from hospitals including Mayo Clinic and Cleveland Clinic reflect droplet, saliva, or contact-mediated spread similar to patterns described for other human herpesviruses in surveillance studies from University of Tokyo and Seoul National University Hospital.

Global seroepidemiology shows variation across regions documented by collaborative networks involving Bill & Melinda Gates Foundation-funded projects, with early-life acquisition emphasized in longitudinal birth cohorts at Karolinska University Hospital and Mount Sinai Hospital. Nosocomial considerations arise in reports from tertiary centers such as Johns Hopkins Hospital and Massachusetts General Hospital.

Clinical Manifestations and Pathogenesis

Clinical associations attributed to HSV-7 in pediatric literature include febrile illnesses and exanthem subitum–like presentations discussed in case series from Great Ormond Street Hospital, Royal Children's Hospital, Melbourne, and pediatric departments at Stanford University School of Medicine. Neurological complications reported in single-center reports from institutions like University College Hospital, London and McGill University Health Centre prompted investigations into neurotropism using models developed at Salk Institute and Institut Pasteur.

Pathogenesis studies reference immunological interactions cataloged in research by teams at Dana-Farber Cancer Institute, Institut Pasteur, and Imperial College London, examining T cell responses, cytokine profiles, and latency in tissues sampled in studies with ethical approvals from centers including University of California, San Francisco and University of Sydney.

Diagnosis and Laboratory Identification

Laboratory identification protocols for HSV-7 have utilized polymerase chain reaction assays, immunofluorescence, and serology adapted from methodologies standardized by World Health Organization reference laboratories and validated at institutions like LabCorp and Quest Diagnostics. Molecular diagnostics draw on primer design strategies reported in publications from Broad Institute and sequencing validation at Wellcome Sanger Institute. Differential diagnosis workflows reference panels used in clinical microbiology departments at Mayo Clinic and Cleveland Clinic to distinguish HSV-7 from HHV-6, Varicella-zoster virus, and enteroviral infections treated at Children's Hospital of Philadelphia.

Treatment and Management

There are no antiviral agents approved specifically for HSV-7; management strategies reported in clinical reports from Johns Hopkins Hospital, Massachusetts General Hospital, and pediatric infectious disease services at University of Toronto focus on supportive care, antipyretics, and management of complications. Off-label use of antivirals such as ganciclovir or foscarnet in severe immunocompromised cases has been described in case reports from transplant centers at Fred Hutchinson Cancer Research Center and Mayo Clinic, with dosing considerations informed by guidance from American Academy of Pediatrics and transplant consortia including European Society for Blood and Marrow Transplantation.

Clinical decision-making often references guidelines from organizations such as Infectious Diseases Society of America and local protocols at tertiary centers like UCSF Medical Center.

Prevention and Public Health Measures

Public health measures addressing HSV-7 emphasize infection control policies in pediatric wards and neonatal units at hospitals like Lucile Packard Children's Hospital and Great Ormond Street Hospital, surveillance activities coordinated by World Health Organization and national public health agencies including Public Health England and Centers for Disease Control and Prevention. Preventive advice in outbreak settings has been informed by infection prevention frameworks from Centers for Disease Control and Prevention and hospital epidemiology units at Johns Hopkins Hospital and University of Michigan Health System. Research into vaccine approaches parallels herpesvirus vaccine efforts at National Institutes of Health vaccine research centers and biotechnology collaborations with companies headquartered near Cambridge, Massachusetts and San Francisco Bay Area.

Category:Human viruses